Nevro Corp
Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well a… Read more
Market Cap & Net Worth: Nevro Corp (NVRO)
Nevro Corp (NYSE:NVRO) has a market capitalization of $224.09 Million ($224.09 Million) as of March 19, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #15035 globally and #5964 in its home market, demonstrating a 1.21% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nevro Corp's stock price $5.84 by its total outstanding shares 38372000 (38.37 Million).
Nevro Corp Market Cap History: 2015 to 2025
Nevro Corp's market capitalization history from 2015 to 2025. Data shows change from $2.59 Billion to $224.09 Million (-19.33% CAGR).
Nevro Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nevro Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.35x
Nevro Corp's market cap is 0.35 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.59 Billion | $69.61 Million | -$67.43 Million | 37.22x | N/A |
| 2016 | $2.79 Billion | $228.50 Million | -$31.78 Million | 12.20x | N/A |
| 2017 | $2.65 Billion | $326.67 Million | -$36.66 Million | 8.11x | N/A |
| 2018 | $1.49 Billion | $387.29 Million | -$49.20 Million | 3.85x | N/A |
| 2019 | $4.51 Billion | $390.25 Million | -$103.69 Million | 11.56x | N/A |
| 2020 | $6.64 Billion | $362.05 Million | -$83.06 Million | 18.35x | N/A |
| 2021 | $3.11 Billion | $386.90 Million | -$131.36 Million | 8.04x | N/A |
| 2022 | $1.52 Billion | $406.37 Million | $3.00 Million | 3.74x | 506.34x |
| 2023 | $825.77 Million | $425.17 Million | -$92.21 Million | 1.94x | N/A |
| 2024 | $142.74 Million | $408.52 Million | -$113.44 Million | 0.35x | N/A |
Competitor Companies of NVRO by Market Capitalization
Companies near Nevro Corp in the global market cap rankings as of March 19, 2026.
Key companies related to Nevro Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Nevro Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, Nevro Corp's market cap moved from $2.59 Billion to $ 224.09 Million, with a yearly change of -19.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $224.09 Million | +56.99% |
| 2024 | $142.74 Million | -82.71% |
| 2023 | $825.77 Million | -45.66% |
| 2022 | $1.52 Billion | -51.15% |
| 2021 | $3.11 Billion | -53.17% |
| 2020 | $6.64 Billion | +47.27% |
| 2019 | $4.51 Billion | +202.24% |
| 2018 | $1.49 Billion | -43.67% |
| 2017 | $2.65 Billion | -4.98% |
| 2016 | $2.79 Billion | +7.63% |
| 2015 | $2.59 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Nevro Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $224.09 Million USD |
| MoneyControl | $224.09 Million USD |
| MarketWatch | $224.09 Million USD |
| marketcap.company | $224.09 Million USD |
| Reuters | $224.09 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.